CN Patent

CN103570613B — 氘代ω-二苯基脲或其盐的多晶型物

Assigned to Suzhou Zehuang Biopharmaceutical Co., Ltd. · Expires 2016-06-15 · 10y expired

What this patent protects

本发明涉及氘代ω-二苯基脲或其盐的多晶型物，具体地，本发明提供了4-(4-{3-[4-氯-3-(三氟甲基)苯基)-酰脲]-苯氧基}-2-(N-1’,1ˊ,1ˊ-三氘代甲基)吡啶酰胺或其盐的多晶型物，即式I所示化合物或其盐的多晶型物。所述多晶型物适合用于制备抑制磷酸激酶(如raf激酶)的药物组合物。

USPTO Abstract

本发明涉及氘代ω-二苯基脲或其盐的多晶型物，具体地，本发明提供了4-(4-{3-[4-氯-3-(三氟甲基)苯基)-酰脲]-苯氧基}-2-(N-1’,1ˊ,1ˊ-三氘代甲基)吡啶酰胺或其盐的多晶型物，即式I所示化合物或其盐的多晶型物。所述多晶型物适合用于制备抑制磷酸激酶(如raf激酶)的药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN103570613B
Jurisdiction
CN
Classification
—
Expires
2016-06-15
Drug substance claim
No
Drug product claim
No
Assignee
Suzhou Zehuang Biopharmaceutical Co., Ltd.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.